de Abreu, Mirhelen Mendes http://orcid.org/0000-0002-2264-0442
Monticielo, Odirlei Andre
Fernandes, Vander
Rodrigues, Dalianna Luise Andrade Souto
da Silva, Cristhiane Almeida Leite
Maiorano, Alexandre Cristovão
Beserra, Fernando dos Santos
Lamarão, Flavia Rachel Moreira
de Veras, Bruna Medeiros Gonçalves
David, Nathalie
Araújo, Magda
Alves, Marcelly Cristinny Ribeiro
Stocco, Matheus Amaral
Lima, Fernando Mello
Borret, Emilly
Gasparin, Andrese Aline
Chapacais, Gustavo Flores
Bulbol, Guilherme Andrade
da Silva Lima, Diogo
da Silva, Natália Jardim Martins
Freitas, Marta Maria Costa
Bica, Blanca Elena Rios Gomes
de Lima, Domingos Sávio Nunes
das Chagas Medeiros, Marta Maria
Funding for this research was provided by:
GSK (GSK Study 207353)
Article History
Received: 10 October 2022
Accepted: 30 March 2024
First Online: 19 April 2024
Declarations
:
: The study was assessed and approved by the Research Ethics Committee of the study’s coordinating center as well as of each participating center. Written informed consent was obtained from each patient.
: Not applicable.
: MMdA has received grant/research support from GSK, Amgen, and Pfizer; and consulting fees from GSK, Pfizer, AstraZeneca, Novartis, Libbs, and Amgen. OAM has received consulting fees and honoraria from AbbVie, Apsen, AstraZeneca, BMS, Boehringer, GSK, Janssen, Novartis, and UCB. VF has received grant/research support from GSK and Novartis; and consulting fees from Janssen and Novartis. FRML, BMGdV, ND, and MA are employees of GSK. DLASR, CALdS, ACM, FdSB, MCRA, MAS, FML, EB, AAG, GFC, GAB, DdSL, NJMdS, MMCF, BERGB, DSNdL, and MMdCM have nothing to disclose.